Prospective Research: Funding, Investors & Team (Oct 2026)
Prospective Research is creating feed incorporated preventative disease management solutions for the aquaculture industry that completely removes the need for antibiotics and medicated feed. The company’s technology platform allows them to modulate bacterial behavior using microbial signaling molecules for the local delivery of therapeutics directly inside the gut of any farmed species. The company seeds trillions of bacterial pharmacies into the microbiome of fin-fish, shrimp, and shellfish, and can selectively turn on bacterial genes encoding bio-active therapeutics inside the animal for protection against bacterial, fungal, and parasitic pathogens.
Prospective Research has raised $200k across 1 funding round on record, the most recent a Debt Financing of $200k announced in Aug 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Prospective Research Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Prospective Research Funding Rounds
Prospective Research Founders and Leadership Team
Contact details for the Prospective Research team: 1 of 1 has an email address on file.
Start 14-day free trial →Prospective Research Funding Compared to Other Biotechnology Startups
Prospective Research's latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Prospective Research in Biotechnology and Beverly
Companies Similar to Prospective Research
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Prospective Research Funding FAQs
What does Prospective Research do?
Prospective Research is creating feed incorporated preventative disease management solutions for the aquaculture industry that completely removes the need for antibiotics and medicated feed. The company’s technology platform allows them to modulate bacterial behavior using microbial signaling molecules for the local delivery of therapeutics directly inside the gut of any farmed species. The company seeds trillions of bacterial pharmacies into the microbiome of fin-fish, shrimp, and shellfish, and can selectively turn on bacterial genes encoding bio-active therapeutics inside the animal for protection against bacterial, fungal, and parasitic pathogens.
How much funding has Prospective Research raised?
Prospective Research has raised $200k across 1 round on record. The most recent is a Debt Financing of $200k announced in Aug 2022.
When did Prospective Research last raise funding?
Prospective Research's most recent funding round on record is a Debt Financing of $200k, announced in Aug 2022.
Who is the CEO of Prospective Research?
Dakota Hamill is listed as CEO at Prospective Research.
Where is Prospective Research headquartered?
Prospective Research is based in Beverly, Massachusetts, United States.
How many employees does Prospective Research have?
Prospective Research is in the 1-10 employee band.
How does Prospective Research's funding compare to other Biotechnology startups?
Prospective Research's latest round of $200k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Prospective Research Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prospective Research is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.